176
Views
26
CrossRef citations to date
0
Altmetric
Research Article

A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis

, , , , , , , , & show all
Pages 508-513 | Received 17 Feb 2010, Accepted 22 Mar 2010, Published online: 11 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kay A. Lawton, Merit E. Cudkowicz, Meredith V. Brown, Danny Alexander, Rebecca Caffrey, Jacob E. Wulff, Robert Bowser, Robert Lawson, Matt Jaffa, Michael V. Milburn, John A. Ryals & James D. Berry. (2012) Biochemical alterations associated with ALS. Amyotrophic Lateral Sclerosis 13:1, pages 110-118.
Read now

Articles from other publishers (25)

Maurits F. J. M. Vissers, Jules A. A. C. Heuberger & Geert Jan Groeneveld. (2021) Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders. International Journal of Molecular Sciences 22:4, pages 1615.
Crossref
Deborah L. de Guingand, Kirsten R. Palmer, Rodney J. Snow, Miranda L. Davies-Tuck & Stacey J. Ellery. (2020) Risk of Adverse Outcomes in Females Taking Oral Creatine Monohydrate: A Systematic Review and Meta-Analysis. Nutrients 12:6, pages 1780.
Crossref
Ojas SrivastavaChris HanstockSneha ChenjiDennell MahDean EurichDaniel TaPeter SeresCollin LukLorne ZinmanAgessandro AbrahaoSimon J. GrahamAngela GengeLawrence KorngutRichard FrayneSanjay Kalra. (2019) Cerebral degeneration in amyotrophic lateral sclerosis. Neurology Clinical Practice 9:5, pages 400-407.
Crossref
Sanjay Kalra. (2019) Magnetic Resonance Spectroscopy in ALS. Frontiers in Neurology 10.
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Miguel Mazón, Juan Francisco Vázquez Costa, Amadeo Ten-Esteve & Luis Martí-Bonmatí. (2018) Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 12.
Crossref
Eman Alraddadi, Ryan Lillico, Jonathan Vennerstrom, Ted Lakowski & Donald Miller. (2018) Absolute Oral Bioavailability of Creatine Monohydrate in Rats: Debunking a Myth. Pharmaceutics 10:1, pages 31.
Crossref
Steven M. HerschGiovanni SchifittoDavid OakesAmy-Lee BredlauCatherine M. MeyersRichard NahinHerminia Diana Rosas. (2017) The CREST-E study of creatine for Huntington disease. Neurology 89:6, pages 594-601.
Crossref
Douglas G. Kondo, Lauren N. Forrest, Xianfeng Shi, Young-Hoon Sung, Tracy L. Hellem, Rebekah S. Huber & Perry F. Renshaw. (2016) Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression. Amino Acids 48:8, pages 1941-1954.
Crossref
Andreas Bender & Thomas Klopstock. (2016) Creatine for neuroprotection in neurodegenerative disease: end of story?. Amino Acids 48:8, pages 1929-1940.
Crossref
José M. García Santos, Alberto Inuggi, Joaquín Gómez Espuch, Carlos Vázquez, Francisca Iniesta, Miguel Blanquer, José María Moraleda & Salvador Martínez. (2016) Spinal cord infusion of stem cells in amyotrophic lateral sclerosis: Magnetic resonance spectroscopy shows metabolite improvement in the precentral gyrus. Cytotherapy 18:6, pages 785-796.
Crossref
Conceicao Moura Mirian, Rita Carvalho Garbi Novaes Maria, SSP Zago Yuri, Junio Eduardo Emanoel & Augusto Casulari Luiz. (2016) Efficacy and effectiveness of drug treatments in amyotrophic lateral sclerosis: A systematic review with meta-analysis. African Journal of Pharmacy and Pharmacology 10:13, pages 257-269.
Crossref
Chafic Y. Karam, Sabrina Paganoni, Nanette Joyce, Gregory T. Carter & Richard Bedlack. (2014) Palliative Care Issues in Amyotrophic Lateral Sclerosis. American Journal of Hospice and Palliative Medicine® 33:1, pages 84-92.
Crossref
Varan Govind. 2016. Magnetic Resonance Spectroscopy of Degenerative Brain Diseases. Magnetic Resonance Spectroscopy of Degenerative Brain Diseases 121 150 .
Richard S. Bedlack, Nanette Joyce, Gregory T. Carter, Sabrina Paganoni & Chafic Karam. (2015) Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 909-936.
Crossref
Adriano Chiò, Marco Pagani, Federica Agosta, Andrea Calvo, Angelina Cistaro & Massimo Filippi. (2014) Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. The Lancet Neurology 13:12, pages 1228-1240.
Crossref
Xueping Chen, Xiaoyan Guo, Rui Huang, Zhenzhen Zheng, Yongping Chen & Hui-fang Shang. (2014) An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis. Neurological Sciences 35:10, pages 1591-1597.
Crossref
Ernesto Miquel, Adriana Cassina, Laura Martínez-Palma, José M. Souza, Carmen Bolatto, Sebastián Rodríguez-Bottero, Angela Logan, Robin A.J. Smith, Michael P. Murphy, Luis Barbeito, Rafael Radi & Patricia Cassina. (2014) Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. Free Radical Biology and Medicine 70, pages 204-213.
Crossref
Lucie Ayach, Christophe Curti, Marc Montana, Pascale Pisano & Patrice Vanelle. (2013) Actualités dans le traitement étiologique de la sclérose latérale amyotrophique. Therapies 68:2, pages 93-106.
Crossref
Matthew Gladman, Merit Cudkowicz & Lorne Zinman. (2012) Enhancing clinical trials in neurodegenerative disorders. Current Opinion in Neurology 25:6, pages 735-742.
Crossref
Martin R TurnerFederica Agosta, Peter Bede, Varan Govind, Dorothée Lulé & Esther Verstraete. (2012) Neuroimaging in amyotrophic lateral sclerosis. Biomarkers in Medicine 6:3, pages 319-337.
Crossref
Maarten Schrooten, Wim Robberecht & Philip Van Damme. (2012) From El Escorial to Awaji: where do we go next with the amyotrophic lateral sclerosis criteria?. Neurodegenerative Disease Management 2:1, pages 135-140.
Crossref
Claire Henchcliffe & M. Flint Beal. 2012. Mitochondrial Dysfunction in Neurodegenerative Disorders. Mitochondrial Dysfunction in Neurodegenerative Disorders 215 230 .
James D Berry & Merit E Cudkowicz. (2011) New considerations in the design of clinical trials for amyotrophic lateral sclerosis. Clinical Investigation 1:10, pages 1375-1389.
Crossref
Lorne Zinman & Merit Cudkowicz. (2011) Emerging targets and treatments in amyotrophic lateral sclerosis. The Lancet Neurology 10:5, pages 481-490.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.